Seer, Inc , a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome.
infoSeer is a micro cap stock with a total market cap of 152.82M.
infoThey trade on the NASDAQ and had their IPO 2 years and 8 months ago.
infoSeer currently employs 164 people.
infoAs of Wednesday, Aug 23 2023, Seer’s share price is $2.39.
News Relating to Seer
The Motley Fool
Why Shares of Seer Are Slumping Wednesday
Wednesday Aug 09 2023 at 15:12
Seer CEO Omid Farokhzad said the company’s sales are facing headwinds. The company lowered annual guidance for revenue.
Zacks Investment Research
Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates
Tuesday Aug 08 2023 at 21:11
Seer, Inc. (SEER) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.37 per share a year ago.
GlobeNewsWire
Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
Thursday Jul 13 2023 at 16:05
REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter of 2023 after market close on Tuesday, August 8, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Seeking Alpha
Seer, Inc. (SEER) Q1 2023 Earnings Call Transcript
Saturday May 13 2023 at 18:38
Seer, Inc. (NASDAQ:SEER ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Carrie Mendivil – IR Omid Farokhzad – CEO, President and Chair David Horn – CFO Conference Call Participants Gabby Shaw – Morgan Stanley Kyle Boucher – TD Cowen Operator Good day. And thank you for standing by.
Zacks Investment Research
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
Tuesday May 09 2023 at 19:52
Seer, Inc. (SEER) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.38 per share a year ago.
GlobeNewsWire
Seer to Report First Quarter 2023 Financial Results on May 9, 2023
Thursday Apr 20 2023 at 16:05
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter of 2023 after market close on Tuesday, May 9, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Seeking Alpha
Seer, Inc. (SEER) Q4 2022 Earnings Call Transcript
Thursday Mar 02 2023 at 22:32
Seer, Inc. (NASDAQ:SEER ) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Carrie Mendivil – Investor Relations Omid Farokhzad – Chair, President and Chief Executive Officer David Horn – Chief Financial Officer Conference Call Participants Derik De Bruin – Bank of America Kyle Boucher – Cowen Tejas Savant – Morgan Stanley Operator Thank you for standing by and welcome to the Seer Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Zacks Investment Research
Seer, Inc. (SEER) Reports Q4 Loss, Misses Revenue Estimates
Thursday Mar 02 2023 at 18:49
Seer, Inc. (SEER) delivered earnings and revenue surprises of 14.29% and 0.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research
Should You Buy Seer (SEER) Ahead of Earnings?
Wednesday Mar 01 2023 at 13:32
Seer (SEER) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks Investment Research
Down -26.63% in 4 Weeks, Here’s Why You Should You Buy the Dip in Seer, Inc. (SEER)
Monday Feb 27 2023 at 11:17
Seer, Inc. (SEER) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks Investment Research
Seer, Inc. (SEER) Moves to Buy: Rationale Behind the Upgrade
Thursday Feb 23 2023 at 13:33
Seer, Inc. (SEER) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
GlobeNewsWire
Seer to Present at the Cowen 43rd Annual Health Care Conference
Tuesday Feb 21 2023 at 16:30
REDWOOD CITY, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Cowen 43rd Annual Health Care Conference in Boston, MA.
GlobeNewsWire
Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
Thursday Feb 09 2023 at 16:05
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the fourth quarter and full year 2022, after market close, on Thursday, March 2, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
GlobeNewsWire
Seer to Present at the J.P. Morgan 41st Annual Health Care Conference
Tuesday Dec 27 2022 at 16:05
REDWOOD CITY, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
Zacks Investment Research
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates
Tuesday Nov 08 2022 at 21:04
Seer, Inc. (SEER) delivered earnings and revenue surprises of 0% and 6.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Seeking Alpha
Seer, Inc. (SEER) CEO Omid Farokhzad on Q3 2022 Results – Earnings Call Transcript
Tuesday Nov 08 2022 at 20:42
Seer, Inc. (NASDAQ:SEER ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Carrie Mendivil – IR Omid Farokhzad – Chair and CEO David Horn – CFO Conference Call Participants Dan Brennan – Cowen Derik De Bruin – Bank of America Neel Ram – Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Seer Inc. Third Quarter 2022 Earnings Call.
GlobeNewsWire
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
Thursday Oct 13 2022 at 16:15
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the third quarter of 2022 on Tuesday, November 8, 2022. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
GlobeNewsWire
Seer to Participate in the Morgan Stanley Global Healthcare Conference
Tuesday Aug 30 2022 at 16:05
REDWOOD CITY, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York City, New York.
Seeking Alpha
Seer, Inc. (SEER) CEO Omid Farokhzad on Q2 2022 Results – Earnings Call Transcript
Saturday Aug 13 2022 at 13:24
Seer, Inc. (NASDAQ:SEER ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Carrie Mendivil – IR Omid Farokhzad – Founder, Chairman & CEO David Horn – CFO Omead Ostadan – President Conference Call Participants Derik De Bruin – Bank of America Neel Ram – Morgan Stanley Kyle Boucher – Cowen Operator Ladies and gentlemen, thank you for standing by, and welcome to the Seer Second Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Zacks Investment Research
Seer, Inc. (SEER) Reports Q2 Loss, Tops Revenue Estimates
Tuesday Aug 09 2022 at 21:04
Seer, Inc. (SEER) delivered earnings and revenue surprises of 5.13% and 17.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewsWire
Seer to Report Second Quarter 2022 Financial Results on August 9, 2022
Thursday Jul 14 2022 at 16:05
REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) — Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the second quarter of 2022 on Tuesday, August 9, 2022. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Seeking Alpha
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2022 Results – Earnings Call Transcript
Friday May 06 2022 at 23:01
Seer, Inc. (NASDAQ:SEER ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Carrie Mendivil – IR Omid Farokhzad – Founder, Chairman & CEO David Horn – CFO Omead Ostadan – President Conference Call Participants Neil Vibhakar – Morgan Stanley Nisarg Shah – Bank of America Merrill Lynch — Analyst Kyle Boucher – Cowen and Company Operator Good day and thank you for standing by. Welcome to the Seer, Inc. First Quarter 2022 Earnings Conference Call.
Zacks Investment Research
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
Wednesday May 04 2022 at 19:33
Seer, Inc. (SEER) delivered earnings and revenue surprises of 7.32% and 18.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewsWire
Seer to Present at the BofA Securities 2022 Healthcare Conference
Thursday Apr 28 2022 at 16:05
REDWOOD CITY, Calif., April 28, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.
GlobeNewsWire
Seer to Report First Quarter Financial Results on May 4, 2022
Thursday Apr 07 2022 at 16:05
REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the first quarter of 2022 on Wednesday, May 4, 2022. Company management will be webcasting a conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.
Seeking Alpha
Seer, Inc. (SEER) CEO Omid Farokhzad on Q4 2021 Results – Earnings Call Transcript
Monday Feb 28 2022 at 20:57
Seer, Inc. (SEER) CEO Omid Farokhzad on Q4 2021 Results – Earnings Call Transcript
GlobeNewsWire
Seer to Present at the Cowen 42nd Annual Health Care Conference
Tuesday Feb 22 2022 at 16:05
REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating virtually in the upcoming Cowen 42nd Annual Health Care Conference.
GlobeNewsWire
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
Wednesday Dec 29 2021 at 08:05
REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference.
Seeking Alpha
Seer, Inc. (SEER) CEO Omid Farokhzad on Q3 2021 Results – Earnings Call Transcript
Tuesday Nov 09 2021 at 22:59
Seer, Inc. (SEER) CEO Omid Farokhzad on Q3 2021 Results – Earnings Call Transcript
Seeking Alpha
Seer: First Pick In Proteomics Portfolio
Friday Sep 17 2021 at 20:36
The proteomics market size was $21 billion in 2019 and is estimated to increase to $64 billion in 2024 (growing annually at 15%), larger than the genomics market. The company’s proteomics diagnostics technology is Proteograph, an integrated solution consisting of consumables, automation instrument and software, which was licensed from Harvard.
Seer Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
Seer’s Altman Z-score is 1.43 which is in the distress zone. This indicates a higher risk of financial distress and potential bankruptcy for the company. It can serve as a warning sign of significant financial challenges, requiring careful consideration by potential investors.
Derived from SEC.GOV filing dataopen_in_new
Seer Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, 1 insider has sold $5.22K of common stock in Seer on the stock market with no insider buying.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
Seer’s Income Quality of 0.72 is lower than its Industry Group of 0.81 (-11.1% lower)
Seer’s Income Quality of 0.72 is in line with its Major Industry Group of 0.71 (1.4% greater)
Seer’s Income Quality of 0.72 is in line with its Sector of 0.75 (-4.0% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
Seer’s Current Ratio of 21.22 is greater than its Industry Group of 3.01 (605.0% greater)
Seer’s Current Ratio of 21.22 is greater than its Major Industry Group of 3.13 (578.0% greater)
Seer’s Current Ratio of 21.22 is greater than its Sector of 2.6 (716.2% greater)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-1.77 & 10.69)
Cannot compare a negative PE Ratio (-1.77 & -0.58)
Cannot compare a negative PE Ratio (-1.77 & -0.4)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
Seer’s PB Ratio of 0.37 is lower than its Industry Group of 2.33 (-84.1% lower)
Seer’s PB Ratio of 0.37 is lower than its Major Industry Group of 1.93 (-80.8% lower)
Seer’s PB Ratio of 0.37 is lower than its Sector of 1.62 (-77.2% lower)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
Seer’s ROE of -0.21 is lower than its Industry Group of 0.02 (-1150.0% lower)
Seer’s ROE of -0.21 is lower than its Major Industry Group of -0.09 (-133.3% lower)
Seer’s ROE of -0.21 is lower than its Sector of -0.03 (-600.0% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
Seer’s ROCE of -0.24 is lower than its Industry Group of 0.01 (-2500.0% lower)
Seer’s ROCE of -0.24 is lower than its Major Industry Group of -0.14 (-71.4% lower)
Seer’s ROCE of -0.24 is lower than its Sector of -0.04 (-500.0% lower)
Derived from SEC.GOV filing dataopen_in_new